Perspective highlights the clinical relevance of food noise in obesity management, indicating the need to combine pharmacological, nutritional, and behavioral interventions.
Obesity treatment has entered a new era with the widespread adoption of glucagon-like peptide-1 (GLP-1) receptor agonists and a striking patient-reported phenomenon, the silencing of persistent, intrusive food thoughts. Formally defined as “food noise”, persistent thoughts about food perceived as unwanted and/or dysphoric that may cause social, mental, or physical harm, this construct has moved from lay discourse into peer-reviewed science [ 1 ], is measurable through validated instruments, including the Ro Allison Indiana Dhurandhar Food Noise (RAID-FN) Inventory and the Food Noise Questionnaire, and resembles cognitive rumination more than physiological appetite [ 1 , 2 ]. Yet food noise remains absent as an explicit therapeutic target from most obesity treatment frameworks. Recent consensus guidance calls for integrating nutritional and lifestyle strategies alongside GLP-1 therapy [ 3 ], and culinary medicine is emerging as a scalable behavioral intervention [ 4 ]. However, no prior framework has positioned food noise as the central unifying construct linking pharmacological, culinary-behavioral, and digital monitoring approaches. This Perspective argues that sustainable obesity management requires treating food noise not merely as a symptom to suppress, but as a measurable therapeutic target across neurobiological, culinary-nutritional, and cognitive-behavioral dimensions.
No takes yet. Share an insight, caveat, or question.
Rizwan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: